Some Birth Control Pills May Increase Cancer Risk
Photo credit: dolgachov/iStock/Getty Images
A study revealed that high-dose estrogen birth control pills (BCPs) may be tied to an increase in breast cancer risk in the year following BCP use. However, some argue that the results must be taken with a grain of salt.
A tentative link between some BCPs and cancer
Low-estrogen BCPs are the most commonly prescribed birth control pills on the market today, and researchers found no link between these medications and an increased risk of breast cancer. However, when they looked at the clinical and prescription records of 1,102 women ages 20 to 49 years diagnosed with breast cancer and 21,952 women without breast cancer in the same age group, they found that those who were prescribed high-dose estrogen BCPs had an increased risk of developing breast cancer.
However, it has been pointed out that the study data isn't extensive enough to make general statements about birth control pills and cancer risk. It was noted that of the women in the study who had breast cancer, only 93 took oral contraceptives for longer than six months — and only 30 of them took the types of oral contraceptives that were suggested to increase the risk of breast cancer by 50 percent in the study.
Should you worry?
The type of BCPs that are most commonly prescribed in the U.S. are low-dose monophasic pills, and not the ones indicated in this study (pills that contain progestin ethynodiol diacetate, and triphasic pills containing a high dose of norethindrone acetate).
Experts urge women to work closely with their physicians to determine which BCP is right for them, and to talk over any concerns they may have at the same time.